Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells by unknown
Medullary  but Not Cortical Thymic Epithelial  Cells 
Present Soluble  Antigens to Helper T Cells 
By Toshiaki  Mizuochi,*  Michiyuki  Kasai,~  Takehiro  Kokuho, S 
Terutaka  Kakiuchi,$  and  Katsuiku  Hirokawa~ 
From the *Department of Blood Products, National Institute of Health, 2-10-35, Kamiosaki, 
Shinagawa-ku, Tokyg 141; the SDepartment of Pathology, Tokyo Metropolitan Institute of 
Gerontology, 35-2, Sakaechq Itabashi-ku, Tokyg 173; and the SDepartment of Allergology, 
Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyg 108, Japan 
Slzmmsry 
Thymic epithelial cell lines (TECs) were established from newborn C57BL/6 mice. They were 
classified into two types (medullary and cortical TECs) by using the monoclonal antibody (Th-3) 
that recognizes the meshwork structure of thymic cortical epithelial cells.  Antigen-presenting 
activity of each TEC was determined by using ovalbumin-specific, I-Ab-restricted helper T  cell 
lines.  It was demonstrated that the medullary but not the cortical TECs functioned as antigen- 
presenting cells. This is the first evidence for the functional difference between the cortical and 
the medullary TEC. 
T 
he thymic environment is the main site of T cell matu- 
ration/differentiation  (1-5).  On arrival in the thymus, 
bone marrow-derived T cell precursors maturate into thymo- 
cytes that undergo intratbymic selection. It is generally be- 
lieved that  cortical thymic epithelial cells (TECs) t  are the 
main cell type that  mediate positive selection,  the process 
of selecting clones capable of self MHC-restricted  antigen 
recognition, whereas medullary macrophages/dendritic cells 
or TECs are responsible for negative sdection,  the process 
of donal elimination  of autoreactive cells (6-8).  There has 
been, however, no direct information that accounts for the 
functional difference of cortical and medullary TECs. In this 
report we demonstrated that cortical TECs are incapable of 
presenting soluble antigens to mature helper T cell lines while 
medullary TECs can function as APC, corroborating the pro- 
posed distinct  roles played by these two types of TECs in 
selecting T  cell repertoires. 
Materials  and Methods 
Mice.  Male and female  C57BL/6 mice were purchased from 
Charles  River  Japan Inc.  (Shizuoka,  Japan) and were mated and 
reared  in our specific  pathogen-free  mouse colony. 
Establishment  of TECs.  Thymi obtained from newborn to 
2-wk-old  mice  were  digested  in  PBS  containing  0.25% trypsin  and 
0.02% EDTA, and were suspended in CaZ+-free  MEM.  The cell 
suspension (104-10  s per dish) was then plated on 4,000-rad irradi- 
1 Abbreviation used in this paper: TEC, thymic epithelial cell. 
ated Swiss 3T3 cells (7  x  10  s per dish) in 60-mm dishes (3802; 
Falcon Labware, Oxnard,  CA) at 35~  in a CO2 (5%) incubator. 
The culture dishes were washed with PBS containing 0.02% EDTA 
to remove 3T3 ceils and thymic fibroblastic cells, and then were 
washed with PIE containing 0.25% trypsin and 0.02% EDTA to 
make a suspension of TEC. Under an inverted microscope, single 
or clusters of the TECs were picked up and transferred to 24-well 
culture plates (3847; Falcon Labware) coated with 4,000-tad irradi- 
ated Swiss 3T3 cells and cultured  in CaZ+-free MEM at 37~ 
This cloning procedure was repeated several times to obtain TECs. 
Antibodies.  Th-3 mouse mAb against mouse thymic cortical 
epithelial cells was produced in our hboratory (9). M5/114 rat mAb 
against mouse I-A  b (10) was supplied by Dr. Uchida (NIH, Tokyo, 
Japan). Rabbit anti-human keratin antibody was purchased from 
Dakopatts (Glostrup,  Denmark). 
lmmunocytochernistry.  The established TECs were cultured on 
eight-hole heavy Teflon-coated slides (Bokusui Brown, New York, 
NY). The slides were washed twice with PBS(+) at room temper- 
ature (RT) and then fixed with 3.7% paraformaldehyde in PIE(-) 
for 5 rain at RT. They were washed three times with PIE(-) at 
4~  and refixed with acetone for 5 min at 4~  Then the slides 
were reacted with primary antibody for 2 h at RT, washed twice 
with chilled PIE(-) at 4~  and reacted with FITC-conjugated 
second antibody for 2 h at RT. The slides were washed with chilled 
PIE(-),  and  then  mounted in PiE( - )-glycerin (1:9). The im- 
munofluorescence photographs  were taken on a Nikon Optiphot 
equipped with an MKC-500 laser confocal scanning microscope 
(Japan Bio-Rad Lab. Co. Ltd., Tokyo, Japan). 
Assay for APC Activity.  OVA-specific,  I-Ab-restricted helper T 
cell lines, MD-23 and KT-17, were used as indicator T ceils. TECs 
were cultured  in the presence of IFN-'y (100 U/ml) for 48 h to 
augment the expression of MHC chss II molecules. They were 
irradiated  at  10,000 tad  and  were  used  as  APC.  104 IFN-~- 
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the presence of various concentrations of antigen, OVA, for 24 h 
in a 96-well flat-bottomed microculture plate (0.2 ml/well) (25860; 
Coming, Cambridge, MA). Culture supernatant (0.1 ml) of each 
cultured well was assayed for Ib2/IL-4 content by measurement 
of [3H]thymidine incorporation  by an Ib2/IL-4-dependent cell 
line, CTLL-2. Standard errors were generally <5% of the mean 
and so have not been included in the Fig. 3 and Table 1. 
Results and Discussion 
We have recently produced a mAb, Th-3, that specifically 
reacts with the meshwork structure of epithelial cells in the 
thymic cortex (9).  This mAb is, therefore, expected to clas- 
sify TECs into cortical and medullary type (see below). We 
have established 42 TEC lines from the thymus of newborn 
C57BL/6  mice and morphologically characterized them to 
be of epithelial nature by their cobblestone appearance (11). 
Among them, TEC1-4C18  and TEC1C6  were chosen for 
further experiments, because of their morphological appear- 
ances representing cortical (with thick cytop]asm and dis- 
tinct cell borders, as shown in Fig. 1 a) and medullary TEC 
(with thin/broad  cytoplasm and indistinct cell borders,  as 
shown in Fig. 1 b), respectively.  These two TEC lines were 
positive with antikeratin antibody showing fine filamentous 
structures (Fig.  1, c and d), and had typical desmosomes and 
tonofibrils in electron micrographs (data not shown). They 
were then examined for reactivity with Th-3 mAb. As shown 
in Fig. 1, e and  f, TEC1-4C18 was positive with Th-3 mAb, 
whereas TEC1C6 was negative. Fig. 1 g confirmed that the 
Th-3 mAb reacts specifically with the meshwork structure 
in the thymic cortex but does not react with thymic meduUa. 
According to these results and our previous observations (9, 
11), it was reasoned that TEC1-4C18 was derived from epi- 
thelial cells in the thymic cortex and that TEC1C6 was de- 
rived from those in the thymic medulla. 
We next examined the antigen-presenting activity of each 
TEC line by using OVA-specific, I-Ab-restricted helper T cell 
Figure 1.  The phase contrast  microscopy (a and b) 
and the immunofluorescence microscopy (c-g) of TEC1- 
4C18 and TEC1C6. (a) TEC1-4C18  showed a cobble- 
stone  pattern  and  distinct  cell borders  due to  thick 
cytoplasm (scale bar, 20 #m). (b) TEC1C6 also showed 
a cobblestone pattern and rehtively indistinct cell borders 
due to thin cytoplasm (scale  bar, 20 ~m). (c) TEC1-4C18 
was positive with antikeratin  antibody showing finely 
filamentous pattern (scale bar, 10 Izm). (d) TEC1C6 was 
also positive with antikeratin  antibody showing finely 
filamentous pattern  (scale bar, 10 ~m). (e) TEC1-4C18 
was positive  with Th-3 mAb (see the text) showing finely 
filamentous pattern (scale  bar, 10 ~rn). ~  TEC1C6 was 
negative with Th-3 mAb (scale bar,  10 Izm). (g) The 
frozen section of C57BL/6 mouse thymus stained with 
Th-3 mAb. The cortex was positive with the Th-3 mAb 
showing  the  meshwork  pattern  (/eft ha  m ,  but  the 
medulla was negative (right  half)  (scale bar,  50 #m). 
1602  Medullary  Thymic Epithelial  Cells Function as APC TECI-4CI8  TECIC6 
i  i  illl,i  i  llll',,~  't  ,  Illlll  I  J IJ,,. 
,62 
........ 
Fluorescence  Intensity 
Figure 2.  FACS  |  analysis  of cell surface  class  II MHC 
antigens expression on TEC lines. The first-step  mAb 
used was M5/114 reacted  with the I-A  b molecule.  FITC 
mouse anti-rat Ig I( chain (MAR. 18.5) was used as the 
second-step mAb. TEC cells were cultured in vitro for 
48 h without IFN-3~ (dotted line) or with IFN-? (solid 
line) before FACS  |  analysis. 
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Figure 3.  Antigen-presenting  activity  of TEC lines 
pretreated with IFN-7 assessed  by the IL-2/II,4  produc- 
tion from helper T cells. Two independently  established 
OVA-specific, l-Ab-restricted  helper T cell lines, MD-23 
(a) and KT-17 (b), were used as indicator  cells. TEC 1C6 
(open circle, solid line) and TEC 1-4C18 (closed circle, dotted 
line) were used as APC. 
lines.  TEC lines were stimulated in vitro with IFN-~/for 
48-72 h to induce a high level of class II MHC antigens (12). 
Fig. 2 illustrates the expression of  class II MHC on each TEC 
line before and after the IFN-'y treatment. Despite comparable 
expression of class II MHC molecules by the two TEC lines, 
there is a clear difference between TEC1-4C18 and TEC1C6  Thymic 
in their ability to present the soluble antigen to two indepen-  epithelial 
dently established OVA-specific, I-Ab-restricted helper T cell  cell 
lines,  MD-23  (Fig.  3 a) and KT-17 (Fig.  3  b). 
Other TEC lines were then examined for their phenotypes 
and the ability to present OVA by using the MD-23 as indi- 
cator cells. Table 1 summarizes the data obtained by analyzing  1-4C18 
10 TEC lines, including TEC1-4C18 and TEC1C6. The im-  1-2 
munostaining studies using Th-3 indicated that the five lines  1-2C1 
(TEC1-4C18, TEC1-2, TEC1-2C1, TEC1CS, and TEC1C9)  1C8 
were of cortical nature, and the other five lines (TEC1C6,  1C9 
TEC1-3, TEC2-3, TEC3-10,  and TEC1-2C2) were of  medul- 
lary nature. Without a single exception, only medullary-type  1C6 
TEC lines showed the antigen-presenting activity, whereas  1-3 
cortical-type TEC lines failed to present soluble antigen to  2-3 
helper T cells. Since stimulation of the OVA-specific helper  3-10 
T  cell line was determined by the level of I1.-2 produced in  1-2C2 
the culture supernatant, the observed failure in presenting 
OVA antigen of cortical-type TEC can hardly be explained 
by lack of costimulatory lymphokine. The failure of cortical- 
type TEC to function as APC was not based on a single dose 
of TEC used in the culture, since essentially the same results 
were obtained by using a wide range of TEC cell numbers 
Table  1.  Medullary  but Not Cortical  Thymic Epithelial 
Cells  Are Able  to Present Soluble  Antigens  to Helper  T  Cells 
APC activity 
(IL-2 production 
by MD-23) 
No  250/~g/ml 
Classification  antigen  antigen 
cpm 
Cortex  96  178 
Cortex  120  95 
Cortex  171  427 
Cortex  101  158 
Cortex  113  134 
Medulla  83  47,902 
Medulla  119  20,902 
Medulla  158  19,026 
Medulla  196  22,709 
Medulla  147  18,792 
APC activity  of TEC lines  were assayed  by the method  described  in Materi- 
als and Methods ([3H]TdR uptake by CTLL-2). The TEC lines stained 
by Th-3 mAb are considered  to be derived from the thymic  cortex. The 
other TECs are considered to be derived from the thymic  medulla (see 
Fig. 1). 
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Finally, the possibility that the'release of toxic cytokines or 
some other harmful products by cortical-type TEC was ex- 
cluded by the mixing experiment; that is, the addition of 
cortical-type TEC did not affect the antigen-presenting ac- 
tivity of medullary type TEC at all (data not shown). These 
results strongly indicate that cortical-type TECs are in general 
incapable of presenting exogenous soluble protein antigens. 
The differential reactivity of the mAb, i.e. Th-3, with cor- 
tical and medullary TEC in situ has been firmly established 
(Fig. 1 g, and reference 9), supporting the validity of typing 
the isolated in vitro lines of TEC with this mAb. Thus, our 
data strongly indicate that cortical and medullary TECs are 
two functionally distinct populations. The medullary TECs 
are more or less like conventional dass II MHC-positive APC 
found in peripheral lymphoid tissues. The cortical TECs, on 
the contrary, are incapable of presenting exogenous soluble 
protein antigens despite the expression of class II MHC mol- 
ecules on the surface. 
We envision four possibilities to account for the observed 
inability of cortical-type TEC in antigen presentation. The 
first possibility is that this type of class II MHC-positive cells 
may not be furnished with the machinery for internalization 
and processing protein antigens, as is the case for keratino- 
cytes induced to express class II MHC molecules by IFN-3, 
(13). If this is the case, these TECs would be capable of pre- 
senting peptide fragments ready for binding to class II MHC 
molecules. In this regard, a recent report by Ransom et al. 
(14) demonstrated that a thymic-derived epithelial cell line 
has defects in its ability to process antigens to produce im- 
munodominant  peptides recognized by some T cell hybridoma, 
although they did not phenotype the TEC. It may be pos- 
sible that the TEC line they established was of cortical rather 
than medullary nature. Alternatively,  it is also possible that 
the cortical TECs do process antigen but much slower than 
medullary TECs. Our preliminary study, however, did not 
support such a possibility, since even when the cortical TEC 
was prepulsed with antigen for 1-3 d before the APC assay, 
it could not present antigens to helper T cells (data not shown). 
Second, even when the cortical TEC can process protein an- 
tigens, these cells might be deficient in giving accessory signals 
mediated by either lymphokines or by certain accessory mol- 
ecules. This possibility, nevertheless, is unlikely, since the stim- 
ulation of the T cell line was assessed  by IL-2/I1..4  production, 
which is generally known to be fully triggered by solely cross- 
linking (multi-valent ligand binding) of the TCK-T3 com- 
pl~ (15). The third possibility is the blockade of peptide 
binding to class II MHC molecules expressed on the surface 
of cortical-type TEC. This model predicts inability of these 
cells to present peptide fragments. Such a blockade could be 
due to occupancy of the groove of surface dass II MHC mol- 
ecules by something such as an invariant chain or by internal 
self-peptide, in case the cells do not synthesize invariant chains. 
It is also possible that some unidentified molecules are bound 
on the surface class II MHC molecules enforcing a tertiary 
structure not suitable for peptide binding. The fourth and 
the most simple explanation is the differential expression of 
the MHC class II molecules in the cortical and in the medul- 
lary TECs. Interestingly, two groups have reported the ex- 
pression of a novel MHC class II molecule in thymic medulla 
but not cortex (16, 17). This novel MHC class II molecule 
might be involved in the presentation of soluble antigens to 
helper T  cells, particularly in the thymic environment. 
It may sound rather surprising that the cortical-type TEC 
lines failed to present soluble antigens to helper T cells, be- 
cause it is generally believed that the thymic cortex is the 
microenvironment where the positive selection  of MHC- 
restricted nominal antigen recognition structure of T  cells 
is operated. One assumption is that class II MHC antigens 
expressed on cortical TEC lines are flee of invariant chain 
(Ii) and preoccupied by self-derived peptides, which might 
determine the "self-MHC restriction" and therefore antigenic 
peptides derived from exogenous nominal antigen are unable 
to be presented by cortical TECs. It would be advantageous 
for the host immune system that this mechanism might pre- 
vent an undesirable stimulation by too many exogenous an- 
tigens that may permeate the thymic cortex (18). 
In conclusion, we classified TEC lines, which we recently 
established from the thymus of newborn C57BL/6 mice, into 
cortical and medullary TEC by immunostaining with Th-3 
mAb, and then demonstrated that the medullary TEC lines 
are able to present soluble antigens to helper T cells, whereas 
the cortical TEC lines are unable to do so.  These results 
strongly suggest that the cortical and the medullary TEC 
may play functionally distinct roles in the selection of the 
T  cell repertoire. 
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